Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Neonatal screening for congenital adrenal hyperplasia in Japan.

Tajima T, Fujikura K, Fukushi M, Hotsubo T, Mitsuhashi Y.

Pediatr Endocrinol Rev. 2012 Oct;10 Suppl 1:72-8. Review.

PMID:
23330248
[PubMed - indexed for MEDLINE]
3.

Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.

Minutti CZ, Lacey JM, Magera MJ, Hahn SH, McCann M, Schulze A, Cheillan D, Dorche C, Chace DH, Lymp JF, Zimmerman D, Rinaldo P, Matern D.

J Clin Endocrinol Metab. 2004 Aug;89(8):3687-93.

PMID:
15292289
[PubMed - indexed for MEDLINE]
4.

Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.

Seo JY, Park HD, Kim JW, Oh HJ, Yang JS, Chang YS, Park WS, Lee SY.

J Perinat Med. 2014 Jan;42(1):121-7. doi: 10.1515/jpm-2013-0154.

PMID:
23989111
[PubMed - indexed for MEDLINE]
5.

Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening.

De Jesús VR, Simms DA, Schiffer J, Kennedy M, Mei JV, Hannon WH.

Clin Chim Acta. 2010 Nov 11;411(21-22):1684-7. doi: 10.1016/j.cca.2010.06.029. Epub 2010 Jul 6.

PMID:
20619255
[PubMed - indexed for MEDLINE]
6.

Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study.

Gidlöf S, Wedell A, Guthenberg C, von Döbeln U, Nordenström A.

JAMA Pediatr. 2014 Jun;168(6):567-74. doi: 10.1001/jamapediatrics.2013.5321.

PMID:
24733564
[PubMed - indexed for MEDLINE]
7.

Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.

Nordenström A, Wedell A, Hagenfeldt L, Marcus C, Larsson A.

Pediatrics. 2001 Oct;108(4):E68.

PMID:
11581476
[PubMed - indexed for MEDLINE]
8.

Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.

Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A.

J Pediatr. 1997 Jan;130(1):128-33.

PMID:
9003862
[PubMed - indexed for MEDLINE]
9.

Newborn screening for congenital adrenal hyperplasia in Sapporo City: sixteen years experience.

Mikami A, Fukushi M, Oda H, Fujita K, Fujieda K.

Southeast Asian J Trop Med Public Health. 1999;30 Suppl 2:100-2.

PMID:
11400741
[PubMed - indexed for MEDLINE]
10.

Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.

Thil'en A, Nordenström A, Hagenfeldt L, von Döbeln U, Guthenberg C, Larsson A.

Pediatrics. 1998 Apr;101(4):E11.

PMID:
9521977
[PubMed - indexed for MEDLINE]
11.

[Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 1. Enzyme immunoassay of dried blood 17 alpha-hydroxyprogesterone and its application to neonatal screening for congenital adrenal hyperplasia].

Fukushi M, Arai O, Mizushima Y, Takasugi N, Fujieda K, Matsuura N.

Nihon Naibunpi Gakkai Zasshi. 1986 Jun 20;62(6):683-96. Japanese.

PMID:
3530828
[PubMed - indexed for MEDLINE]
12.

Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.

Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J.

J Clin Endocrinol Metab. 2007 Jul;92(7):2581-9. Epub 2007 Apr 24.

PMID:
17456574
[PubMed - indexed for MEDLINE]
13.

False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.

Fingerhut R.

Steroids. 2009 Aug;74(8):662-5. doi: 10.1016/j.steroids.2009.02.008. Epub 2009 Mar 9.

PMID:
19463687
[PubMed - indexed for MEDLINE]
14.

Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.

Schwarz E, Liu A, Randall H, Haslip C, Keune F, Murray M, Longo N, Pasquali M.

Pediatr Res. 2009 Aug;66(2):230-5. doi: 10.1203/PDR.0b013e3181aa3777.

PMID:
19390483
[PubMed - indexed for MEDLINE]
15.

A case of 11beta-hydroxylase deficiency detected in a newborn screening program by second-tier LC-MS/MS.

Peter M, Janzen N, Sander S, Korsch E, Riepe FG, Sander J.

Horm Res. 2008;69(4):253-6. doi: 10.1159/000113027. Epub 2008 Jan 21.

PMID:
18204274
[PubMed - indexed for MEDLINE]
16.

Evaluation of neonatal screening for congenital adrenal hyperplasia.

Honour JW, Torresani T.

Horm Res. 2001;55(4):206-11.

PMID:
11598376
[PubMed - indexed for MEDLINE]
18.

Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia.

Gleeson HK, Wiley V, Wilcken B, Elliott E, Cowell C, Thonsett M, Byrne G, Ambler G.

J Paediatr Child Health. 2008 Oct;44(10):554-9. doi: 10.1111/j.1440-1754.2008.01383.x.

PMID:
19012627
[PubMed - indexed for MEDLINE]
19.

Congenital adrenal hyperplasia and the second newborn screen.

Chan CL, McFann K, Taylor L, Wright D, Zeitler PS, Barker JM.

J Pediatr. 2013 Jul;163(1):109-13.e1. doi: 10.1016/j.jpeds.2013.01.002. Epub 2013 Feb 12. Erratum in: J Pediatr. 2013 Jul;163(1):308.

PMID:
23414665
[PubMed - indexed for MEDLINE]
20.

Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry.

Lacey JM, Minutti CZ, Magera MJ, Tauscher AL, Casetta B, McCann M, Lymp J, Hahn SH, Rinaldo P, Matern D.

Clin Chem. 2004 Mar;50(3):621-5. Epub 2003 Dec 4.

PMID:
14656905
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk